Legal attitude: Art. 17 para. 1 MAR - confidential information. Br> The Management Board of Athos Venture Capital S.A. with its registered office in Warsaw (hereinafter: the Issuer), informs that today it convened the Extraordinary General Meeting of Shareholders on January 29, 2018 (ESPI report No. 20/2017), which in the agenda includes, inter alia, change of the subject of activity. br> The Issuer's Management Board recommends changing the subject of operations by starting operations in the area of development of technological solutions - with particular emphasis on virtual reality (VR) technology - for the medical sector. br> The main areas of the Company's operations would be: br> - creation of medical simulators in virtual reality technology, with particular focus on education in the field of clinical and aesthetic medicine; br> - implementation of innovative solutions in the field of VR simulators and br> - products and services addressed to scientific and training institutes (including medical universities), medical associations and companies producing medical devices. br> br> Implementation of the above development plans will be possible after acceptance by the Extraordinary General Meeting of Shareholders of the change in the subject of activity. br> Immediately after successful adoption of a resolution regarding a change in the subject of activity, the Management Board will start work on the preparation and publication of a detailed development strategy of the Company. At the same time, in such a situation, actions will be taken to withdraw the application for entry into the register of managers of an alternative investment company (ASI), and in the case of entry in the register - to submit a request for deletion from this register. Br>
Source: company website, investor relations, current and periodic reports.